scholarly article | Q13442814 |
P50 | author | Ming-Jen Hsu | Q57051044 |
P2093 | author name string | Joen-Rong Sheu | |
Yi Chang | |||
Thanasekaran Jayakumar | |||
Manjunath Manubolu | |||
Wei-Cheng Lee | |||
Jiun-Yi Li | |||
Shou-Huang Hung | |||
P2860 | cites work | A novel antioxidant, octyl caffeate, suppression of LPS/IFN-γ-induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells | Q44403220 |
Topotecan inhibits VEGF- and bFGF-induced vascular endothelial cell migration via downregulation of the PI3K-Akt signaling pathway | Q45714409 | ||
Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide | Q46755225 | ||
Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes | Q46758917 | ||
Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers | Q48138664 | ||
Selection of Protein Phosphatase 2A Regulatory Subunits Is Mediated by the C Terminus of the Catalytic Subunit | Q59385877 | ||
Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death | Q63303664 | ||
Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression | Q64377899 | ||
Autophosphorylation‐activated protein kinase inactivates the protein tyrosine phosphatase activity of protein phosphatase 2A | Q71650129 | ||
Sedation in the intensive care unit | Q83222051 | ||
PME-1 modulates protein phosphatase 2A activity to promote the malignant phenotype of endometrial cancer cells | Q88079269 | ||
Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling | Q24532278 | ||
Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits | Q24598280 | ||
Serine/threonine phosphatases: mechanism through structure | Q28263239 | ||
Ketamine-induced neuronal cell death in the perinatal rhesus monkey | Q28297451 | ||
Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation | Q28638545 | ||
The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
Atherosclerosis. the road ahead | Q29618972 | ||
Flicking the switches: phosphorylation of serine/threonine protein phosphatases | Q30467951 | ||
Atherosclerosis is an inflammatory disease | Q33762068 | ||
Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. | Q34272789 | ||
Andrographolide enhances nuclear factor-kappaB subunit p65 Ser536 dephosphorylation through activation of protein phosphatase 2A in vascular smooth muscle cells | Q34675805 | ||
Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug | Q34988290 | ||
Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. | Q35023644 | ||
Synaptic modulation in pain pathways. | Q36214190 | ||
General anesthetics and vascular smooth muscle: direct actions of general anesthetics on cellular mechanisms regulating vascular tone | Q36723066 | ||
PKB and the mitochondria: AKTing on apoptosis | Q36918414 | ||
Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation | Q37143323 | ||
Pathogenesis of atherosclerosis: A multifactorial process. | Q37276377 | ||
Inflammation and plaque vulnerability | Q37307660 | ||
Non-opioid IV adjuvants in the perioperative period: pharmacological and clinical aspects of ketamine and gabapentinoids | Q37981947 | ||
The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles | Q37998958 | ||
Structure, regulation, and pharmacological modulation of PP2A phosphatases | Q38122081 | ||
Acute and chronic psychological stress as risk factors for cardiovascular disease: Insights gained from epidemiological, clinical and experimental studies | Q38563397 | ||
All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase | Q38617799 | ||
Adenosine monophosphate-activated protein kinase regulates platelet-derived growth factor-BB-induced vascular smooth muscle cell migration | Q39214312 | ||
Autoregulation of protein phosphatase type 2A expression | Q41024570 | ||
An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? | Q42204682 | ||
Alpha 2-adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells | Q42453225 | ||
Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay | Q42670691 | ||
Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix. | Q42809218 | ||
Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells | Q42811143 | ||
Inhibition of vascular smooth muscle cell proliferation by the vitamin E derivative pentamethylhydroxychromane in an in vitro and in vivo study: pivotal role of hydroxyl radical-mediated PLCgamma1 and JAK2 phosphorylation. | Q42987549 | ||
Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway | Q44052627 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P577 | publication date | 2017-11-27 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition | |
P478 | volume | 18 |
Search more.